Merger Outlook For 2004: Pfizer Fortunes Key To More M&A, Analysts Say
Executive Summary
A demonstration by Pfizer of renewed vigor following the acquisition of Pharmacia could kick off another round of merger & acquisition activity in 2004, securities analysts predict